Mumbai, June 25 -- The scrip was listed at Rs 395.20, a 90% premium to the initial public offer (IPO) price. The stock is currently frozen at its upper limit of 5% over its listing price.

The counter hit a high of Rs 414.95 and a low of Rs 395.20. About 5.71 lakh shares of the company changed hands at the counter.

Avience Biomedicals' IPO was subscribed 355.05 times. The issue opened for bidding on 18 June 2026 and it closed on 22 June 2026. The price band of the IPO was fixed between Rs 196 to Rs 208 per share.

The IPO comprised fresh issue of 14,53,800 equity shares. The promoter and promoter group shareholding diluted to 64.59% from 87.89% pre-issue.

The company intends to utilize the net proceeds to fund its working capital requir...